AI assistant
Episurf — Director's Dealing 2017
Jun 21, 2017
3157_iss_2017-06-21_4f0c1c46-6927-4541-a21a-7d4abcadbe89.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Insider transactions in Episurf Medical
Episurf Medical's (NASDAQ: EPIS B) Chairman of the Board Dennis D. Stripe acquired shares in Episurf Medical on June 15 and he now owns 11,500 Class B-shares. Board member Laura Shunk has acquired shares in Episurf Medical on June 7 and she now owns 10,750 Class B-shares.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
Email: [email protected]
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical's Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.
Insider transactions in Episurf Medical